NASDAQ:BPMX - BioPharmX Stock Price, News, & Analysis

Sign in or create an account to add this stock to your watchlist.
$0.13 -0.01 (-6.99 %)
(As of 03/20/2019 04:00 PM ET)
Previous Close$0.1440
Today's Range$0.13 - $0.1658
52-Week Range$0.05 - $0.33
Volume24.68 million shs
Average Volume5.67 million shs
Market Capitalization$29.04 million
P/E RatioN/A
Dividend YieldN/A
BetaN/A
BioPharmX Corporation, a specialty pharmaceutical company, develops and commercializes novel prescription and over-the-counter (OTC) products that address dermatology and women's health markets. The company offers VI2OLET, an OTC molecular iodine dietary supplement that addresses cyclic breast discomfort, as well as alleviates the symptoms of fibrocystic breast condition (FBC). Its clinical-stage product candidates include BPX01, a topical antibiotic gel that has completed Phase II clinical trials for the treatment of inflammatory lesions of acne; BPX04, a topical antibiotic, which is in pre-Phase II feasibility study for the treatment of inflammatory lesions of rosacea; BPX02, a development stage product candidate for aesthetic dermatology applications; and BPX03, a molecular iodine tablet, which has completed pre-Phase III clinical trial for the treatment of periodic breast pain associated with FBC and cyclic mastalgia. The company serves pharmaceutical companies; physician's practices, including obstetricians and gynecologists, dermatologists, and general practitioners; and retail customers through retail sales channels and/or pharmacy outlets. It has collaboration and license agreement with Iogen LLC to develop molecular iodine formulations; and collaboration and supply agreement with NuTech Medical, Inc. to develop products in the field of dermatology. The company is headquartered in Menlo Park, California.

Receive BPMX News and Ratings via Email

Sign-up to receive the latest news and ratings for BPMX and its competitors with MarketBeat's FREE daily newsletter.

Industry, Sector and Symbol

Industry Biotechnology
Sub-IndustryN/A
SectorMedical
Current SymbolNASDAQ:BPMX
CUSIPN/A
CIKN/A
Phone650-889-5020

Debt

Price-To-Earnings

Sales & Book Value

Annual SalesN/A

Profitability

Miscellaneous

EmployeesN/A
Market Cap$29.04 million
Next Earnings Date6/6/2019 (Estimated)
OptionableNot Optionable

BioPharmX (NASDAQ:BPMX) Frequently Asked Questions

What is BioPharmX's stock symbol?

BioPharmX trades on the NASDAQ under the ticker symbol "BPMX."

How were BioPharmX's earnings last quarter?

BioPharmX Corporation (NASDAQ:BPMX) issued its earnings results on Thursday, March, 14th. The company reported ($0.01) earnings per share (EPS) for the quarter, topping the Thomson Reuters' consensus estimate of ($0.02) by $0.01. The firm earned $0.01 million during the quarter. View BioPharmX's Earnings History.

When is BioPharmX's next earnings date?

BioPharmX is scheduled to release their next quarterly earnings announcement on Thursday, June 6th 2019. View Earnings Estimates for BioPharmX.

What is the consensus analysts' recommendation for BioPharmX?

1 Wall Street analysts have issued "buy," "hold," and "sell" ratings for BioPharmX in the last year. There are currently 1 buy rating for the stock, resulting in a consensus recommendation of "Buy." View Analyst Ratings for BioPharmX.

Has BioPharmX been receiving favorable news coverage?

News headlines about BPMX stock have been trending somewhat positive recently, InfoTrie Sentiment Analysis reports. The research group rates the sentiment of media coverage by reviewing more than six thousand blog and news sources. The firm ranks coverage of publicly-traded companies on a scale of -5 to 5, with scores closest to five being the most favorable. BioPharmX earned a coverage optimism score of 0.7 on InfoTrie's scale. They also assigned news articles about the company a news buzz of 7.0 out of 10, indicating that recent media coverage is likely to have an impact on the company's share price in the next several days.

Who are some of BioPharmX's key competitors?

What other stocks do shareholders of BioPharmX own?

Who are BioPharmX's key executives?

BioPharmX's management team includes the folowing people:
  • Dr. Kin Foong Chan, Exec. VP of Research & Technology (Age 44)
  • Dr. David S. Tierney M.D., Pres, CEO, CFO and Director (Age 54)
  • Dr. José Zayas, Sr. VP of Operations
  • Ms. Joyce Goto, VP ,CAO & Controller (Age 45)
  • Dr. R. Kehl Sink, Sr. VP of Intellectual Property & Legal

How do I buy shares of BioPharmX?

Shares of BPMX can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.

What is BioPharmX's stock price today?

One share of BPMX stock can currently be purchased for approximately $0.1330.

How big of a company is BioPharmX?

BioPharmX has a market capitalization of $29.04 million.

What is BioPharmX's official website?

The official website for BioPharmX is http://www.biopharmx.com.

How can I contact BioPharmX?

The company can be reached via phone at 650-889-5020.


MarketBeat Community Rating for BioPharmX (NASDAQ BPMX)

Community Ranking:  2.5 out of 5 (star star half star)
Outperform Votes:  37 (Vote Outperform)
Underperform Votes:  38 (Vote Underperform)
Total Votes:  75
MarketBeat's community ratings are surveys of what our community members think about BioPharmX and other stocks. Vote "Outperform" if you believe BPMX will outperform the S&P 500 over the long term. Vote "Underperform" if you believe BPMX will underperform the S&P 500 over the long term. You may vote once every thirty days.
This page was last updated on 3/20/2019 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.

Yahoo Gemini Pixel